Illinois 2025-2026 Regular Session

Illinois House Bill HB5001

Introduced
2/4/26  
Refer
2/10/26  
Refer
3/18/26  
Report Pass
3/24/26  
Engrossed
4/17/26  
Refer
4/21/26  
Refer
4/28/26  
Report Pass
5/6/26  

Caption

INS-MAMMOGRAM COVERAGE

Impact

The bill significantly changes the insurance landscape regarding breast cancer screening in the state. By ensuring that insurers cover these tests without cost-sharing, it aims to eliminate financial barriers that may prevent women from seeking necessary medical evaluations. Proponents argue that this measure could lead to earlier diagnosis, which is critical for successful treatment outcomes. Moreover, it aligns with national healthcare guidelines, emphasizing the importance of preventive care in combating breast cancer.

Summary

House Bill 5001, known as the Mammogram Coverage Bill, aims to mandate comprehensive insurance coverage for breast cancer screenings, including various types of mammograms and related diagnostic tests. The bill stipulates that every insurance policy must provide coverage for low-dose mammography and diagnostic mammograms without imposing any deductibles or co-pays. Furthermore, it requires coverage for additional imaging tests like ultrasound and MRI under specific medical circumstances. The bill is designed to enhance accessibility to essential breast cancer screenings to improve early detection rates.

Sentiment

The sentiment around HB5001 is largely positive among healthcare advocates and patient rights organizations, who praise it as a crucial step towards improving women's health services. Supporters highlight that the bill addresses an essential aspect of public health by ensuring that breast cancer screenings are accessible to all women, regardless of their financial situation. However, some opposition exists focusing on the potential strain on insurance companies, which may lead to increased premiums as they adjust to the mandated coverage requirements.

Contention

Contentious points often arise around the financial implications of the mandate for insurance companies. Opponents argue that while the intention behind the bill is commendable, the obligation could increase operational costs for insurers, potentially leading to higher insurance premiums across the board. Another point of contention is the potential strain on medical resources, particularly if there is a surge in demand for screenings as a result of increased access. Balancing enhanced coverage with sustainable healthcare financing is a critical discussion surrounding this legislation.

Companion Bills

No companion bills found.

Previously Filed As

IL SB2921

INS-EYE MEDICATION COVERAGE

IL SB1358

INS CD-PET SCAN COVERAGE

IL HB1141

GENERAL ANESTHESIA COVERAGE

IL SB3258

INS-RENTAL VEHICLE COVERAGE

IL SB2899

INS CD-STUTTERING COVERAGE

IL HB4464

INS-DENTAL COVERAGE REIMBURSE

IL SB3668

MEDICAID-MAMMOGRAPHY

IL HB5451

MEDICAID-MAMMOGRAPHY

IL HB3605

INS-GENETIC TESTING & SCREEN

IL SB2762

INS-SEIZURE DETECTION DEVICE

Similar Bills

IL HJR0064

FY27 HOUSE REVENUE ESTIMATE

IL HB5425

NATURAL ORG REDUCE REG-ACT

IL SB2704

PROBATE-SMALL ESTATES

IL SB2910

INS-FAIR PLAN ASSOCIATION

IL SB4006

CLIMATE RISK & STRENGTHEN HOME

IL HJR0012

ED HEALTH INSURANCE TASK FORCE

IL SR0756

MEMORIAL-REP. B. FLYNN CURRIE

IL HR0746

HFS REIMBURSEMENT PARITY